Does ALPRAZOLAM Cause Salivary hypersecretion? 53 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 53 reports of Salivary hypersecretion have been filed in association with ALPRAZOLAM (Alprazolam). This represents 0.1% of all adverse event reports for ALPRAZOLAM.
53
Reports of Salivary hypersecretion with ALPRAZOLAM
0.1%
of all ALPRAZOLAM reports
0
Deaths
7
Hospitalizations
How Dangerous Is Salivary hypersecretion From ALPRAZOLAM?
Of the 53 reports, 7 (13.2%) required hospitalization, and 5 (9.4%) were considered life-threatening.
Is Salivary hypersecretion Listed in the Official Label?
Yes, Salivary hypersecretion is listed as a known adverse reaction in the official FDA drug label for ALPRAZOLAM.
What Other Side Effects Does ALPRAZOLAM Cause?
Drug abuse (8,827)
Toxicity to various agents (7,157)
Completed suicide (4,873)
Drug ineffective (4,040)
Overdose (2,967)
Drug dependence (2,743)
Somnolence (2,461)
Intentional overdose (2,389)
Death (2,317)
Suicide attempt (2,313)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which ALPRAZOLAM Alternatives Have Lower Salivary hypersecretion Risk?
ALPRAZOLAM vs ALPROSTADIL
ALPRAZOLAM vs ALTEPLASE
ALPRAZOLAM vs ALTERNARIA ALTERNATA
ALPRAZOLAM vs ALTHIAZIDE
ALPRAZOLAM vs ALTHIAZIDE\SPIRONOLACTONE